REGN REGENERON PHARMACEUTICALS

2026Q1 · CUSIP 75886F107 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over

Holders

1,386

Δ holders QoQ

Breadth percentile

Top 34%

Whale holders

323

Δ whales

-2

Inst. holding value

$64.5B

New positions

137

Closed positions

129

Price momentum (1Q)

-20.6%

Put / Call

30/32

Breadth history (34 quarters)

Past Lit Events & Aftermath 20 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 2%	-20.6%	—
2025Q3	Top 7%	+11.2%	-7.4%
2024Q3	Top 3%	-8.0%	-21.5%
2024Q2	Top 16%	-33.6%	-41.9%
2024Q1	Top 5%	+21.8%	-23.0%
2023Q4	Top 4%	+3.6%	+26.2%
2023Q3	Top 10%	+18.9%	+23.9%
2023Q1	Top 2%	+6.3%	+5.7%
2022Q4	Top 3%	+1.5%	+10.3%
2022Q3	Top 9%	+1.8%	+3.2%
2022Q1	Top 14%	-4.7%	+9.2%
2021Q4	Top 7%	+4.5%	-1.0%
2021Q3	Top 2%	-1.8%	+2.6%
2021Q2	Top 3%	+0.4%	-0.8%
2020Q2	Top 1%	-8.7%	-22.4%
2020Q1	Top 0%	+10.8%	+1.1%
2019Q4	Top 6%	+40.9%	+56.1%
2019Q1	Top 3%	-2.7%	+11.0%
2018Q4	Top 13%	-28.1%	-29.1%
2018Q3	Top 9%	+21.2%	-7.3%

Show all 20 events

Options Sentiment

Put holders

QoQ: 0

Call holders

QoQ: -3

See methodology →

Fundamentals

PE (TTM)

16.4

EPS (TTM)

$40.96

EPS YoY

+4.1%

Revenue (TTM)

$14.9B

Revenue YoY

+5.9%

Net margin

29.6%

ROE

14.1%

Debt ratio

23.1%

FCF (TTM)

$4.1B

Dividend (TTM)

$3.58

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.